Dashboard
1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 15.26%
- Healthy long term growth as Operating profit has grown by an annual rate 23.13%
- Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 35.84
2
Positive results in Dec 24
3
With ROE of 18.40%, it has a Very Attractive valuation with a 1.82 Price to Book Value
4
Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-13.49%
0%
-13.49%
6 Months
7.03%
0%
7.03%
1 Year
37.16%
0%
37.16%
2 Years
70.59%
0%
70.59%
3 Years
198.53%
0%
198.53%
4 Years
74.5%
0%
74.5%
5 Years
52.82%
0%
52.82%
The United Laboratories International Holdings Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.79%
EBIT Growth (5y)
23.13%
EBIT to Interest (avg)
35.84
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.29
Sales to Capital Employed (avg)
0.86
Tax Ratio
19.19%
Dividend Payout Ratio
38.70%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
24.45%
ROE (avg)
15.26%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.82
EV to EBIT
7.57
EV to EBITDA
6.22
EV to Capital Employed
2.16
EV to Sales
1.57
PEG Ratio
NA
Dividend Yield
114.94%
ROCE (Latest)
28.56%
ROE (Latest)
18.40%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
15,182.50
13,180.40
15.19%
Operating Profit (PBDIT) excl Other Income
4,156.50
2,993.00
38.87%
Interest
73.90
94.90
-22.13%
Exceptional Items
-60.50
-48.10
-25.78%
Consolidate Net Profit
2,984.40
1,838.50
62.33%
Operating Profit Margin (Excl OI)
232.60%
178.30%
5.43%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 15.19% vs 12.70% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 62.33% vs 54.15% in Dec 2022
About The United Laboratories International Holdings Ltd. 
The United Laboratories International Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






